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Methods: Reviewing available literature providing evidence for the
new technologies available for treating:
1- Chronic Venous Disease (including superﬁcial varicose veins
and deep venous obstructions).
2- Deep Vein thrombosis (DVT).
Results: RCTs showed that ultrasound-guided endovenous thermal or
chemical ablation of superﬁcial varicose veins are as eﬀective as surgi-
cal ligation and stripping with the additional advantages of being min-
imally invasive, with less complications and more patient satisfaction,
potential treatment in out-patient setup and early return to work.
Stenting of chronic deep venous obstruction is safe, eﬀective in
improving symptoms and treating venous leg ulcers. Catheter-directed
thrombolysis and pharmaco-mechanical thrombolysis are both eﬀec-
tive in treating acute DVT and reducing post-thrombotic
manifestations.
Conclusion: Current evidence shows that management of venous dis-
eases is now shifting towards minimally invasive interventions with
very promising results. Given the lots of research work done in the ﬁeld
nowadays and evolving technologies provided by manufacturers, it will
soon be the standard of practice oﬀered for patients with chronic
venous disease.
http://dx.doi.org/10.1016/j.ehj.2013.12.071
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Purpose: The aim of this work was to examine the relation between the
severity of silent ischemic episodes detected by ambulatory ECG
recording and the angiographic severity of coronary artery disease
(CAD).
Methods: Fifty patients with chronic stable angina pectoris and type 2
diabetes mellitus were enrolled in the study.Among the study group,
there were 33 males and 17 females; and their mean age was
61  6.5 years. All patients were submitted to 24-hours ambulatory
ECG recording and coronary angiography with estimation of Gensini
score. According to the frequency of silent ST-segment depression epi-
sodes, patients were classiﬁed into two groups.
Group I: 24 patients with ST-segment depression frequency <8.
Group II: 26 patients with ST-segment depression frequency P8.
Results: In patients with ST-segment depression frequency P8, there
were signiﬁcantly higher number of left main coronary artery (LMCA)
disease, and signiﬁcantly higher Gensini score (Table 1). Sensitivity of
ST-segment depression frequencyP8 in predicting Gensini scoreP20
was 60%, speciﬁcity was 56%, positive predictive value was 58%, neg-
ative predictive value was 58%, and overall accuracy was 58% (Kap-
pa = 0.412,p= 0.014). Gensini score showed signiﬁcant positive
correlation with ST-segment depression frequency
(r= 0.391,p= 0.005), with maximum ST-segment depression
(r= 0.346,p= 0.014), and with total ST-segment depression duration
(r= 0.495,p= 0.0003).
Conclusion: Patients with type 2 diabetes mellitus who had more fre-
quent silent myocardial ischemia by ambulatory ECG recording were
found to have angiographically more extensive CAD as assessed by
Gensini score. Gensini score was found to be signiﬁcantly correlated
to the frequency of silent ST-depression, maximum ST-depression,
and total ST-depression duration.
See Table 1.
http://dx.doi.org/10.1016/j.ehj.2013.12.072
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Background: The trace elements are essential micronutrients that have
important physiological, metabolic, and homeostatic roles in the
human being. Up till now the actually role and eﬀect of the trace ele-
ments on myocardial metabolism speciﬁcally on congenital cyanotic
heart disease is not entirely clear.
Objective: This study aimed to detect the serum level of selected trace
elements (zinc, copper and selenium), and evaluate its eﬀect and rela-
tion in congenital cyanotic heart disease.
Methodology: This study had enrolled upon 50 children, included 30
patients with congenital cyanotic heart disease and 20 age matched
normal healthy children as control group. All groups were subjected
to thorough clinical history, examination and speciﬁc cardiac investi-
gation as well as detection of serum levels of zinc, copper and selenium.
All results were statistical analyzed.
Results: The current study revealed that a highly signiﬁcant decrease in
the serum level of both zinc and selenium (p < 0.00l and p < 0.01),
however serum copper level has non signiﬁcant increase in congenial
cyanotic heart disease, were (p > 0.95). There was non signiﬁcant cor-
relation between the mean serum levels of trace elements and the
hemodynamic parameters,. Also there were non signiﬁcant correla-
tions between the age and sex of the studied group and the mean serum
levels of these trace elements (p > 0.05).
Conclusion: Congenital cyanotic heart disease were associated with a
highly signiﬁcant decrease in the mean serum selenium and zinc levels,
when compared with control group and non signiﬁcant increase the
mean serum copper levels. Changes in these trace elements suggested
to play an important role in the pathogenesis of myocardial damage
in congenital cyanotic heart disease.
http://dx.doi.org/10.1016/j.ehj.2013.12.073
Three-dimensional speckle tracking echocardiography for left atrial and
left ventricular function in hypertrophic cardiomyopathy mutation car-
riers
Mohammad Abdulghani Abdulzaher a,b,1
aCardiology Department, Al-Hussain University Hospital, Badr
tower, Al-Fatah school street, Al-Vilal District, Benha, Qaliubeia,
Cairo, Egypt, bCardiology Department, Babelshaa’reia University
Hospital, Benha, Cairo, Egypt. Email address: dr_m.abdelghan-
i@yahoo.com
1 Tel.: 01125235320, Secondary phone: 01111792798
Abstracts / The Egyptian Heart Journal 66 (2014) 1–35 25
Introduction: Hypertrophic cardiomyopathy (HCM) is the most com-
mon heritable cardiac disorder and is the leading cause of sudden
cardiac death in young individuals and athletes. It is caused by muta-
tions in genes that encode for sarcomere proteins and is characterized
by unexplained left ventricular (LV) hypertrophy (LVH). However,
the penetrance of LVH is incomplete, highly variable, and age depen-
dent. Recent reports have suggested that HCM mutation carriers
without overt LVH frequently have risk factors for sudden cardiac
death. Genetic testing provides a certain diagnosis for HCM muta-
tion carriers before development of LVH, though it is hampered by
being complex and unfeasible in up to 50% of HCM family members
as genetic mutations are only identiﬁed in 40–60% of HCM patients.
Therefore, an alternative family screening approach for early diagno-
sis of HCM patients is required. LV diastolic dysfunction as the ﬁrst
marker of disease in preclinical HCM mutation carriers has been pre-
viously detected by tissue Doppler imaging (TDI). However, the
reported sensitivity and speciﬁcity were highly variable. Other imag-
ing tools for the early identiﬁcation of myocardial systolic dysfunc-
tion and myocardial structural alteration such as two–dimensional
speckle tracking echocardiography (2DSTE) and integrated backscat-
ter echocardiography, respectively were also investigated albeit with
mixed results. Recently, cardiac magnetic resonance (CMR) imaging
with its high spatial resolution has displayed subtle myocardial struc-
tural changes but also intramyocardial crypts in these mainly asymp-
tomatic patients. However the availability of CMR is limited and the
analysis is time consuming. Quantiﬁcation of LA size and function is
a good diagnostic tool for LV diastolic function as well as a predictor
of therapy response and major cardiovascular outcomes in various
cardiac patients including HCM patients. The assessment of left atrial
(LA) longitudinal strain using 2DSTE has recently been shown as a
feasible and reproducible marker of LA function. Three–dimensional
speckle tracking echocardiography (3DSTE) is an emerging tool
building on the strengths of 2DSTE for better quantiﬁcation of myo-
cardial volumes and mechanics including assessment of dyssynchrony
in one fast analysis. In this study, we tested the ability of 3DSTE to
distinguish HCM mutation carriers from normal subjects primarily
by detecting subtle abnormalities in LA size and longitudinal strain
as surrogate markers of early LV dysfunction. Likewise, we evaluated
the magnitude and timing of systolic myocardial deformation to
detect any abnormalities that can deﬁne early systolic dysfunction
in these subjects.
Methods and results: A total of 80 subjects with normal LV ejection
fraction (EF) were divided into 3 groups: HCM mutation carriers
(n= 23), manifest HCM patients (n= 28), and normal controls
(n= 29). They prospectively underwent 3DSTE for left atrial (LA)
and LV strain analysis. HCM mutation carriers showed signiﬁcantly
higher LA minimum volume (ml/m2) (17  6 vs. 14  4, respectively,
P= 0.03) and a signiﬁcantly lower peak atrial longitudinal strain
(PALS) (%), (27  5 vs. 31  7, respectively, P= 0.02) when com-
pared to controls. However, no diﬀerences were found in global or
regional LV systolic myocardial deformation between carriers and nor-
mal controls. Manifest HCM patients, compared to carriers showed
signiﬁcantly higher LA minimum (27  10 vs. 17  6, respectively,
P < 0.001) and maximum volume (42  14 vs. 32  8, respectively,
P= 0.007) as well as lower LA EF (%) (35  8 vs. 47  9, respec-
tively, P < 0.001) and PALS (17  5 vs. 27  5, respectively,
P < 0.001). Comparing LV strain, HCM patients showed reduced glo-
bal longitudinal (11  4 vs. 16  3, respectively, P < 0.001) and
area strain (35  6 vs. 40  5, respectively, P= 0.005). In addition,
there was higher mechanical dyssynchrony (SDI) in the long-axis
motion (13.6  10 vs. 8.3  4, respectively, P= 0.007).
Conclusion: HCM mutation carriers could be distinguished from
healthy subjects using 3DSTE through detection of LA dysfunction
that might indicate subtle LV dysfunction. No diﬀerences were found
in LV systolic myocardial deformation between both groups. The exact
clinical value of 3DSTE in family screening for HCM needs to be fur-
ther evaluated.
http://dx.doi.org/10.1016/j.ehj.2013.12.074
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Background: Left atrial (LA) contractility plays an important role in
maintenance of cardiac output in patients with left ventricular systolic
dysfunction. Although left atrial contractile dysfunction has been
reported in dilated cardiomyopathy of ischemic and non-ischemic eti-
ology, the mechanism of LA dysfunction and the pathophysiologic
determinants of left atrial size and function have not been adequately
investigated in these patients.
Aim of the work: The aim of this study was to evaluate LA size and
contractile function in patients with dilated cardiomyopathy of ische-
mic and idiopathic etiology and to explore the mechanism and deter-
minants of LA dilation and contractile dysfunction in these patients.
Methods: 35 patients with ischemic dilated cardiomyopathy, 15
patients with idiopathic dilated cardiomyopathy and 30 control sub-
jects were studied with transthoracic conventional echocardiography,
tissue Doppler imaging (TDI) and coronary angiography (CA). Left
ventricular (LV) size, systolic and diastolic functions as well as mitral
regurgitation (MR) were evaluated. Left atrial volume at mitral valve
opening (Vmax), onset of atrial systole, determined by onset of the P
wave of the electrocardiogram (Vp) and mitral valve closure (Vmin)
was determined with two-dimensional echocardiography. The left
atrial contractile function was assessed by means of active emptying
fraction (ACTEF= {Vp  Vmin}/Vp%) and TDI for assessment of
late diastolic velocity of the mitral annulus and left atrial free wall.
Results: Left atrial Vmax was greater while ACTEF and left atrial wall
velocity were lower in cardiomyopathy patients compared with the
control subjects (79 ± 32 vs. 59 ± 18; P< 0.05, 27.6 ± 13 vs.
42 ± 15; P< 0.05 and 10.2 ± 4.7 vs. 16.2 ± 5.4; P< 0.05,
respectively). Vmax , ACTEF and left atrial wall velocity were simi-
larly aﬀected in both types of cardiomyopathy, ischaemic and idio-
pathic, under the same loading conditions (74 ± 24 vs. 91 ± 46;
P> 0.05, 29 ± 12 vs. 27 ± 13; P> 0.05 and 10 ± 5 vs. 11 ± 4;
P> 0.05, respectively). The determinants of ACTEF were left atrial
volume, left ventricular ejection fraction (EF), E/e’ and MR severity.
Conclusion: Left atrial enlargement and contractile dysfunction are
common in patients of dilated cardiomyopathy regardless of its aetiol-
ogy, with the same degree of contractile dysfunction in both ischemic
and idiopathic cardiomyopathies under similar loading conditions.
This dysfunction is related to worse LV systolic and diastolic function,
Table 1
Shows comparison between two groups in angiographic severity.
ST-depression
Frequency <8 (n= 24)
ST-depression
Frequency P8 (n= 26)
p
LMCA disease 2 (8.3%) 8 (30.8%) 0.048
Gensini score 21.3  10.75 35.4  17.3 0.001
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